Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-382-4 | CAS number: 10138-04-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In aqueous solution ammonium iron bis(sulphate) dissociates forming sulfate, ammonium and ferric ions. The skin sensitization of this substance can therefore be assessed by evaluating the sensitization of substances forming the same ions upon dissolution. The skin sensitizing potential of Iron(II) Sulfate and Ammonium chloride was tested by local lymph node assay (LLNA) in female rats and Buehler Test, respectively. The results showed that both substances did not induce sensitization. Since GHS criteria for skin sensitization are not met ammonium iron(III) sulfate is not classified.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- This animal test determines the sensitization potential of a chemical by assessment of proliferative responses in lymph nodes draining the site of chemical application. Following exposure to metal salts lymph node cell (LNC) proliferative activity was assessed via determining the incorporation of [methyl-3H]thymidine by scintillation counting.
- GLP compliance:
- not specified
- Type of study:
- other: Local Lymph Node Assay in F344 rats
- Specific details on test material used for the study:
- Solutions of Iron(II) Sulfate in DMSO: Water (4:1)
- Species:
- other: rat
- Strain:
- other: F344
- Sex:
- female
- Details on test animals and environmental conditions:
- Female F344 rats, 6-8 weeks old
- Vehicle:
- other: DMSO: water (4:1)
- Concentration:
- c(FeSO4) / (w/v%): 0.0, 0.5, 1.0, 2.5, 5.0
- No. of animals per dose:
- 3
- Details on study design:
- Three animals (n = 3) were used per group. Rats received 100 µl of each concentration of the test chemical on the dorsum of both ears daily for 3 consecutive days. Control rats received an equal volume of vehicle alone. Animals were sacrificed 24 h following the final exposure. The draining auricular lymph nodes were excised and pooled and weighed for each experimental group. A single suspension of lymph node cells (LNC) was prepared. Cell suspensions (1×106 cells/200 µl) were seeded into 96-well tissue culture plate (5 wells per group) and cultured at 37°C in a humidified atmosphere of 5% CO2 in air with 0.5 µCi [methyl-3H]thymidine (3HTdR). After 18 h culture, LNC were harvested with an automatic cell harvester and 3HTdR incorporation was determined by liquid scintillation counting. A stimulation index (SI), the increase in 3HTdR incorporation relative to vehicle-treated controls, was derived for each experimental group. With the same method, skin sensitization potential of potassium dichromate and cobalt chloride was tested.
- Parameter:
- SI
- Value:
- 1.28
- Test group / Remarks:
- c(FeSO4) = 0.5%
- Parameter:
- SI
- Value:
- 0.61
- Test group / Remarks:
- c(FeSO4) = 1.0%
- Parameter:
- SI
- Value:
- 1.64
- Test group / Remarks:
- c(FeSO4) = 2.5%
- Parameter:
- SI
- Value:
- 1.12
- Test group / Remarks:
- c(FeSO4) = 5.0%
- Cellular proliferation data / Observations:
- Exposure to FeSO4 failed to induce significant lymph node responses at all concentrations (see table 1). In comparable tests, exposure to potassium dichromate (K2Cr2O7) and cobalt chloride (CoCl2) induced strong proliferative responses.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Exposure to FeSO4 failed to induce significant lymph node responses at all concentrations investigated. In comparable tests, exposure to potassium dichromate (K2Cr2O7) and cobalt chloride (CoCl2) induced strong proliferative response. Since GHS criteria for skin sensitization are not met, iron(II) sulfate is not classified.
- Executive summary:
The skin sensitizing potential of Iron(II) Sulfate was tested by local lymph node assay (LLNA) in female rats. Following exposure to solutions of the metal salt (concentration: 0% to 5%), the lymph node cell proliferative response was assessed by measuring the incorporation of [methyl-3H]thymidine. According to this article by Ikarashi et al. (published in 1992), exposure to FeSO4 failed to induce significant lymph node responses at all concentrations investigated. In comparable tests, exposure to potassium dichromate (K2Cr2O7) and cobalt chloride (CoCl2) induced strong proliferative responses. Since GHS criteria for skin sensitization are not met, iron(II) sulfate is not classified.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 1987-03-16 to 1987-04-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-6 (Skin Sensitisation)
- Version / remarks:
- EPA Pesticide Assessment GuidelinesSubdivision FHazard Evaluation: Human and Domestic AnimalsSeries 81: Acute Toxicity and Irritation Studies§ 81-6 "Dermal Sensitization Study"EPA 540/9-82-025, November 1982, revised at November 1984
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- This existing study was considered to be sufficient for assessing the sensitization potential of the substance to be registered. Additional animal testings of the substance are not considered necessary by the applicant.
- Specific details on test material used for the study:
- Name: Hoe 092297 - Substanz technischCode: Hoe 092297 OG ZC99 0001Appearance: white, crystallinePurity: 99,1 %Sample received at: 25.02.87Storage: at ca. 4°C, in a Refrigerator
- Species:
- guinea pig
- Strain:
- other: Pirbright-White
- Sex:
- female
- Details on test animals and environmental conditions:
- Strain: Hoe: DHPK (SPFLac)Origin: Hoechst AG, Kastengrund, SPF - ZuchtBody weight at start: average 240 g (= 100 %)minimum 209 g (- 13 %)maximum 263 g (+ 10 %)Number of animals: 30 (test animals and control animals) Age at start: ca. 8 WochenRandomization: 939/87Keeping of animals: groups of 5 animals per cage (material: Makrolon, Typ4)on softwood bedding Temperature: 22 + 3°CHumidity: 50 + 20 %Duration of lighting: 12 h per dayAcclimatization: at least 5 daysFeeding: ERKA-Mischfutter Nr. 8300, ad libitumWater: tap water in plastic bottles, ad libitumIdentification of the animals: marks on the coat with KMnO4, numbered cages
- Route:
- intradermal
- Vehicle:
- other: Freud's adjuvant, isotonic saline
- Concentration / amount:
- Test group:spot 1: 2x 0.1 ml 50 % Freud's adjuvantspot 2: 2x 0.1 ml 5 % test material in salinespot 3: 2x 0.1 ml 5 % testmaterial in 50 % Freud's adjuvantControl group:spot 1: 2x 0.1 ml 50 % Freud's adjuvantspot 2: 2x 0.1 ml salinespot 3: 2x 0.1 ml 50 % Freud's adjuvant
- Day(s)/duration:
- animals were monitored for 7 days
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: isotonic saline
- Concentration / amount:
- test group: 0.5 ml 25% test material in salinecontrol group: 0.5 ml saline
- Day(s)/duration:
- 2 days occlusive conditions; subsequently, animals were monitored for 10 days
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: isotonic saline
- Concentration / amount:
- 0.5 ml 5 % test material in saline
- Day(s)/duration:
- 1 day under occlusive conditions, skin reactions were assessed during the following 2 days
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- Test group: 20 animalscontrol group: 10 animals
- Details on study design:
- Day 1: - intradermal induction, injection of different preparations at 3 spots within an 2x4 cm area on the back of the animals- Weighting of the animalsDay 1-7: area of application is monitoredDay 9: epicutaneous induction (occlusive conditions), application of the test solution on a patch (2x4 cm), covering the injection spots of the intradermal inductionDay 11: removal of the occlusive dressing and assessment of skin irritation Day 12-21: monitoring of the animalsDay 22: dermal challenge (occlusive conditions), application of the test solution on a patch (2x2 cm) on the left flank of the animalsDay 23: removal of the occlusive dressingDay 24: Assessment of skin reactionsDay 25: - assessment of skin reactions- Weighting of the animals
- Positive control substance(s):
- no
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- Erythema and weak edema after injection of Freud’s adjuvant with and without test material. Very weak to weak edema after application of test material in saline. Formation of scab in all groups. Weight development was not affected by the treatment.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 %
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- Erythema and weak edema after injection of Freud’s adjuvant with and without test material. Very weak to weak edema after application of test material in saline. Formation of scab in all groups. Weight development was not affected by the treatment.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Erythema and weak edema after injection of Freud’s adjuvant. Formation of scab in all groups. Weight development was not affected by the treatment.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Erythema and weak edema after injection of Freud’s adjuvant. Formation of scab in all groups. Weight development was not affected by the treatment.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Ammonium chloride was not sensitizing in this maximization test.
- Executive summary:
In this study by Hoechst AG the skin sensitizing potential of ammonium chloride was examined by an guinea pig maximization test. The test material was applied after intradermal and epicutaneous induction under occlusive conditions for 24 h. 10 % of the test group showed very weak erythema 24 and 48 h after application. All other animals (test group and control group) showed no treatment related reactions. Since the classification criteria were not met, ammonium chloride was not classified.
Referenceopen allclose all
Table 1: The draining LNC proliferative activity in the rat following exposure to iron sulfate.
LNC: lymph node cells; mean cpm: mean counts/minute ,values from five culture wells.
c(FeSO4) / (w/v%) | LNC proliferation 3HTdR incorporation / mean cpm x 10 -3 | standard deviation / cpm x 10 -3 | stimulation index |
0.0 | 2.35 | 0.18 | - |
0.5 | 3.02 | 0.32 | 1.28 |
1.0 | 1.42 | 0.16 | 0.61 |
2.5 | 3.87 | 0.23 | 1.64 |
5.0 | 2.63 | 0.17 | 1.12 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Justification for classification or non-classification
The GHS criteria for skin sensitization is not met and ammonium iron(III) sulfate is not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.